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Abstract
Introduction: Intraperitoneal administration of local anesthetic in combination with an opioid, for the relief 
of postoperative pain, has already been reported after laparoscopic cholecystectomy. This study aimed to 
assess the analgesic effect of the intraperitoneal administration of bupivacaine and morphine, in patients 
undergoing laparoscopic cholecystectomy.
Methods: 90 patients (30 patients in each group) were included in a double blind, randomized manner. At the 
end of laparoscopic cholecystectomy, the patients were intraperitoneally treated with 30 ml of: physiological 
saline (Group 1) or 0.25% bupivacaine (Group 2) or 0.25% bupivacaine + 2 mg morphine (Group 3). Patient’s 
postoperative pain was evaluated using a visual analogue scale and a verbal rating score. The postoperative 
analgesic requirement was assessed by the total dose of Ketorolak, administered by intravenous or intra-
muscular route. Pain, vital signs, supplemental analgesics consumption and side effects were recorded for 
all patients for 12h.
Results: There were no difference between the three groups, regarding pain scores (et rest and coughing) 
during the study, except in the fi rst 6 h, when scores were lower for patients receiving intraperitoneal bipuva-
caine + morphine (p<0.05).
Conclusions: In the patients undergoing laparoscopic cholecystectomy, the intraperitoneal administration 
of bupivacaine + morphine, reduced the analgesic requirements during the fi rst 6 postoperative hours com-
pared with the control groups. The combination of intraperitoneal bupivacaine 0.25% and morphine was more 
effective for treatment of pain after laparoscopic cholecystectomy. © 2011 All rights reserved
Keywords: laparoscopic cholecystectomy, bupivacaine, opioids, morphine, anesthetics, local anesthetics, 
    pain, surgery.
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Introduction
Laparoscopic cholecystectomy (LC) is currently 
considered to be a relatively minor operation (1,2). 
It has been classifi ed as a basket procedure (analo-
gous to shopping with a supermarket basket) in 
the UK government’s publications on day-surgery 
(3). But, an important factor that limits recovery 
is postoperative pain. Intraperitoneal instillation 
of local anesthetics is a simple method of analge-
sia and should be considered in addition to other 
morphine sparing analgesics such as NSAIDs, ac-
etaminophen and incisional local anesthetics (4, 5).
Laparoscopic cholecystectomy, in healthy pa-
tients is routinely performed at our hospital on a 
day case basis. Intraperitoneal instillation of lo-
cal anesthetic around the operative site has been 
used as an analgesic technique on the premise 
that conduction from visceral sites is blocked 
and may reduce the extent of referred pain to the 
shoulder, which results of nerves C3, C4, C5 dia-
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phragm innervation, gas distension and diaphrag-
matic shift ing, in the postoperative period (5,6,7). 
However, in previous studies of intraperitoneal 
local anesthetics following laparoscopic chole-
cystectomy it has not been possible consistently 
to demonstrate reliable analgesic eff ects (8,9,10). 
Th is may be related to nociceptive conduction 
from incisional sites that are not blocked by local 
anesthetics given into the intraperitoneal cavity.
Diff erent regimens have been proposed to re-
lieve pain aft er laparoscopic surgery, such as 
non-steroidal anti-infl ammatory drugs, local 
wound anesthetics, intraperitoneal anesthetics 
and saline, gas drainage, heated gas low-pres-
sure gas and nitrous oxide pneumoperitoneum.. 
Multimodal analgesia (combined use of two or 
more analgesic agents) for pain relief aft er op-
eration is believed to the more advantageous 
than single modality treatment, especially when 
diff erent sites of action are involved, or when a 
synergistic eff ect, or both, is achieved (11,12).
Th e aim of the present study was to determine the 




A prospective, randomized, double-blind study was 
undertaken with written informed consent which 
was obtained from all patients. Each study group 
consistent of 30 ASA I-II patients scheduled to un-
dergo elective LC for cholelithiasis under general 
anesthesia. Th e individuals, of both sexes, were 
aged 26-63 yr. Criteria for exclusion were: psychiat-
ric disease, allergic reactions to drugs or local anes-
thetics, morbid obesity and severe chronic disease.
Patients were also excluded, if they underwent sur-
gery for acute cholecystitis or if the operation was 
converted to an open procedure. All patients were 
given a standard anesthetics comprising propofol 
2-4 mg/kg, fentanyl 2 μg/kg, ondasetron 4 mg, i.v., 
Rocuronium 0.6 mg/kg was used for muscular re-
laxation. Patients lungs were ventilated without 
nitrous oxide, but with sevofl urane 1-1.5%, with 
oxygen. Suppositories of diclofenac 100 mg, were 
administered at the induction of anesthesia. Stan-
dard patient monitoring was used. Lung ventilation 
was adjusted to maintain an end-tidal carbon di-
oxide partial pressure of 4.7-5.3 kPa. Intra-abdom-
inal pressure during laparoscopy was automatical-
ly maintained at 12 mmHg by a CO2 insuffl  ator. 
At the end of successful LC, patients were allo-
cated randomly to one of three groups. Group 1 
(n=30) received physiological sodium chloride 30 
ml, intraperitoneally. Group 2 (n=30) bupivacaine 
0.25% 30 ml intraperitoneally. Group 3, (n=30) 
bupivacaine 0.25% 30 ml, intraperitoneally plus 
morphine 2mg. Each patient received the test 
solution in the following way: 15 ml was sprayed 
to both sides of the diaphragm, and another 15 
ml, was directly applied to the gall bladder bed 
and to the right subhepatic space. All patients 
received ondasetron i.v., during operation (13). 
During closure of the wound, the incisional sites 
were infi ltrated with bupivacaine 20 ml, 0.25%, 2.5 
mg/ml, with epinephrine 5 μg/ml, in all patients (14).
Residual neuromuscular blockade was antagonized 
with a mixture of neostigmine and atropine (15).
In the postoperative period, patients were assessed 
on awakening and then at 1, aft er 6 and aft er 12 
hours by a trained observer. Intraperitoneal pain 
at rest and during deep inspiration and any pain in 
the right shoulder were assessed on a visual ana-
logue scale (VAS). Th e degree of postoperative pain 
was assessed with a VAS (0-100 mm) (0 - no pain, 
100 - severe pain) at rest and on coughing. Patients 
were asked about the location of pain, whether at 
the shoulder, incision sites and/or inside the abdo-
men. Pain relief was rated by the patients on a 4 
point verbal rating score (VRS). 0 = no pain re-
lief; 1 = partial pain relief; 2 = good pain relief; 3 = 
excellent pain relief, complete analgesia. Th e VRS 
recorded during the study was summed obtaining 
the total pain relief score for that period. Total pain 
relief scores were used widely in analgesic clinical 
trials – higher scores signifying better analgesia.
Nausea and sedation were assessed also on a 
similar VAS, representing “no nausea” and “fully 
awake” on the left  and “worst imaginable nau-
sea” and “very drowsy” on the right, respec-
tively. Pain, sedation and nausea scores for the 
fi rst 6 h aft er operation were summed (11, 24).
Statistical analysis
Nominal data were analyzed with the χ2-test. 
Statistical analyses was performed with the soft -
ware SPSS. p< 0.05 was considered signifi cant.
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Results
Th e groups were similar in regard to gender, age, 
height, weight and duration of the pneumoperito-
neum (Table 1).
Values are mean (_+SD). Th ere were no signifi -
cant diff erences between groups. Th ere were no 
signifi cant diff erences between the three groups 
in relation to pain scores (at rest or on coughing) 
during the study except in the fi rst 6 h, in regard 
to incisional and intra-abdominal pain scores, 
respectively, in which pain was signifi cantly 
lower (p<0.05) in those patients receiving intra-
peritoneal bupivacaine plus morphine (Figure 1).
Scores of 2 (good relief) or 3 (complete relief) 
on the VRS were reported more oft en by pa-
tients in Group 3, which resulted in higher to-
tal pain relief scores, although the diff erences 
were not signifi cant aft er six hours (Figure 2). 
26 patients of the Group 1, 16 in Group 2 and 2 in 
Group 3 needed a rescue dose, of postoperative an-
algesic drugs, in the fi rst 6 h. No diff erences in the 
incidence of nausea/vomiting were observed be-
tween groups (40%, 33%, and 40% in Groups 1, 2 
and 3, respectively). None of the other above-men-
tioned side-eff ects was reported by any of the groups.
Discussion 
Th e results of this study demonstrated that intra-
peritoneal administration of bupivacaine 0.25% 
30 ml, plus morphine 2mg, signifi cantly reduced 
postoperative analgesic requirements during the 
fi rst 6 h, aft er laparoscopic cholecystectomy, com-
pared with the control group. Furthermore, the an-
algesic requirements were signifi cantly lower dur-
ing the entire study in patients belong to Group 
3, who received intraperitoneal bupivacaine 
0.25% 30 ml, plus morphine at the end of surgery. 
Accordingly, previously we injected the drugs to 
the subdiaphragmatic area. However, we found 
a low incidence of shoul-
der pain in all treatment 
groups, because the re-
sidual intraperitoneal car-
bon dioxide was defl ated 
carefully by the surgeon. 
Our study shows that the 
intraperitoneal adminis-
tration of bupivacaine is 
eff ective aft er LC, as noted 
in other reports, although 
the amount of pain reduc-
tion and duration of eff ect 
Group 1 Group 2 Group 3
Gender (m/f) 3/27 4/26 3/27
Age (yr) 46 (13) 48 (13) 50 (9)
Height (cm) 164 (4) 164 (7) 165 (7)
Weight (kg) 75 (8) 81 (7) 78 (13)
Duration of pneumo-
peritoneum 57 (13) 68 (20) 66 (21)
TABLE 1.  Patients characteristics
FIGURE 1.  VAS score at placebo, bupivacain and bupivacain+morphine group.
FIGURE 2.  VRS score at placebo, bupivacain and bupivacain+morphine group.
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were limited (16-19). It has been suggested that 
the poor results in pain reduction, when intra-
peritoneal local anesthesia is used, aft er LC – com-
pared with those in the available gynecological 
literature - are due to visceral and parietal pain 
being more severe than shoulder pain aft er LC 
(20-24). On the other hand, in a recent study the 
intraperitoneal instillation of bupivacaine during 
LC resulted in lower pain scores and in reduced 
morphine requirements compared with placebo. 
We used ketorolak, a non-opioid analgesic 
with minor adverse eff ects and with power-
ful pain-relieving activity, including surgical 
pain, in our study to assess analgesic require-
ments aft er operation. Our data also showed 
a signifi cant decrease in supplemental ketoro-
lak in patients given morphine intraperitoneal.
We used bupivacaine and low doses of morphine, 
intraperitoneally to achieve the additional an-
algesic benefi t from the combined eff ect of a lo-
cal anesthetic with an opioid agonist (25-29).
Intraperitoneal local anesthetics would be ex-
pected to be useful for treating visceral pain. In 
our study it is likely that intraperitoneal bupi-
vacaine in the right hypochondrial area had an 
analgesic eff ect (30). It signifi cantly reduced to-
tal abdominal pain during inspiration and there 
was a trend towards lower scores for total ab-
dominal pain at rest and total both shoulder pain. 
Local anesthetic toxicity is a serious prob-
lem, which limits dosage and effi  cacy. Bupi-
vacaine is used traditionally as it has a long 
duration of action. It can cause central and 
cardiovascular toxicity and there have been re-
ports of accidental deaths and cardiac arrest (36).
We did not observe any side-eff ects attributable to 
the local anesthetic. We did not measure plasma 
concentrations of bupivacaine, but several reports 
have shown that the range of mean plasma con-
centration (0.92 – 1.14 μg/ml) aft er the intraperi-
toneal administration of plain bupivacaine (100 – 
150 mg) is well below the toxic concentration of 3 
μg/ml. Th e doses of bupivacaine in our study were 
lower than those thought to cause systemic toxicity.
Our results are consistent with other studies in 
which intraperitoneal administration of local an-
esthetic has been shown to have a modest analgesic 
eff ect (31, 32). Of 13 clinical trials considered in a 
systemic review it was found that the intraperito-
neal administration of bupivacaine 50-200 mg, in 
volumes of 10-100 ml, produced signifi cant anal-
gesia in seven studies where supplemental analge-
sic consumption was signifi cantly reduced (33-35).
In summary, we have demonstrated that the in-
traperitoneal administration of morphine plus 
bupivacaine 0.25% in patients undergoing lapa-
roscopic cholecystectomy reduces ketorolak re-
quirements during fi rst 6 h aft er the operation 
compared to a control group. However, the intra-
peritoneal application of bupivacaine 0.25% com-
bined with morphine, at the end of surgery is ef-
fective in achieving reduction in pain (36, 37, 38).
Conclusion
Th erefore, we concluded that combination of in-
traperitoneal bupivacaine and morphine was 
better than, bupivacaine without morphine, or 
placebo, for pain relief aft er laparoscopic cho-
lecystectomy. Th e surgeons involved in the 
study continue to use this method of analge-
sia as part of their routine practice (40, 41).
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